As advised via Pharmac Tender announcement 31 May 2018 there is to be a change in the listing and future sole supply.

New listing from 1 December 2018

Metformin-Apotex Tab 850 mg 500               Pharmacode 2401002                Schedule price $7.04

Incumbent brand

Metformin Mylan Tab 850 mg 500                  Pharmacode 2479265          Schedule price $7.82

Reference pricing will apply from 1 February 2019

HML (Hospital Supply Status) commences 1 February 2019 and CSS (Community Supply Status) commences 1 May 2019

As of the date of this notification ProPharma / PWR cannot accept Metformin-Mylan for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author